Changzhou Qianhong Biopharma CO.,LTD

Shenzhen Stock Exchange 002550.SZ

Changzhou Qianhong Biopharma CO.,LTD Inventory for the year ending December 31, 2023: USD 84.79 M

Changzhou Qianhong Biopharma CO.,LTD Inventory is USD 84.79 M for the year ending December 31, 2023, a 9.07% change year over year. Inventory is the value of goods held by a company for sale or used in the production process.

Changzhou Qianhong Biopharma CO.,LTD Inventory for the year ending December 31, 2022 was USD 77.74 M, a 23.30% change year over year.
Changzhou Qianhong Biopharma CO.,LTD Inventory for the year ending December 31, 2021 was USD 63.05 M, a 30.25% change year over year.
Changzhou Qianhong Biopharma CO.,LTD Inventory for the year ending December 31, 2020 was USD 48.41 M, a 37.11% change year over year.
Changzhou Qianhong Biopharma CO.,LTD Inventory for the year ending December 31, 2019 was USD 35.31 M, a -1.23% change year over year.

Key data

Date	Inventory	Goodwill	Total Assets	Current Liabilities

Shenzhen Stock Exchange: 002550.SZ

Changzhou Qianhong Biopharma CO.,LTD

CEO	Mr. Ke Wang
IPO Date	Feb. 18, 2011
Location	China
Headquarters	No. 90 Changjiang Middle Road
Employees	1,067
Sector	Healthcare
Industries Biotechnology 3D Printing Chemicals & Advanced Materials Composite Materials Personal Care Pet Food Pharmaceuticals Plastics

Description

Changzhou Qianhong Biopharma CO.,LTD engages in the research and development, production, and sale of bio-pharmaceutical products with a focus on polysaccharides and enzymes in China. The company provides various API products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; kallidinogenase kallikrein for use in the treatment of microcirculation disorders; and heparinoid. It also offers a range of preparations, such as nadroparin calcium PFS, enoxaparin sodium PFS, dalteparin sodium PFS, and asparaginase and heparin sodium injections for use as anticoagulants. In addition, the company exports its products. Changzhou Qianhong Biopharma CO.,LTD was founded in 1971 and is headquartered in Changzhou, China.

Key trends

Past 5 years